Contemporary Amperex Technology (03750) has repurchased a total of 15.99 million A shares by the end of January.
Ningde Times (03750) announced that as of January 31, 2026, the company has repurchased a total of 15,990,800 shares of A shares through the Shenzhen Stock Exchange trading system by means of centralized competitive trading, accounting for 0.3628% of the total A-share equity of the company on the same day. The highest transaction price was RMB 317.63 per share, the lowest transaction price was RMB 231.50 per share, and the total transaction amount was RMB 4.386 billion (excluding transaction costs).
Contemporary Amperex Technology (03750) announced that as of January 31, 2026, the company has repurchased a total of 15.9908 million A-shares through the Shenzhen Stock Exchange stock trading system by means of centralized bidding trading, accounting for 0.3628% of the total A-shares on that day. The highest transaction price was 317.63 yuan per share, the lowest transaction price was 231.50 yuan per share, and the total transaction amount was 4.386 billion yuan (excluding transaction fees).
Related Articles

BOCOM INTL (03329) and BANKCOMM have entered into an administrative and non-administrative functional support service sharing framework agreement.

Bio-Thera Solutions (688177.SH) signed a commercialization agreement with Avalon Pharma for BAT3306 (Paboli Zhu Monoclonal Antibody) injection.

FIRST TRACTOR(00038): North China Institute and YTO Diesel Engine entered into an industrial product purchase agreement.
BOCOM INTL (03329) and BANKCOMM have entered into an administrative and non-administrative functional support service sharing framework agreement.

Bio-Thera Solutions (688177.SH) signed a commercialization agreement with Avalon Pharma for BAT3306 (Paboli Zhu Monoclonal Antibody) injection.

FIRST TRACTOR(00038): North China Institute and YTO Diesel Engine entered into an industrial product purchase agreement.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


